Eton Pharmaceuticals, Inc. (ETON) compared with its closest peers (ARCT, CTMX, LFCR, CYTK, ASMB): P/E 142.9 vs industry 17.2. Peer set by Pharmaceutical Products; 10 comparable drugmakers. First-party data.
Arcturus Therapeutics, CytomX Therapeutics, Lifecore Biomedical, Cytokinetics, Assembly Biosciences, Viridian Therapeutics, Rockwell Medical, Kura Oncology, Spero Therapeutics and Aytu BioPharma share Eton Pharmaceuticals's sub-industry, pharmaceutical makers.
| Company | Market Cap | P/E |
|---|---|---|
| Arcturus Therapeutics Holdings Inc. (ARCT) | $382.29M | -2.5 |
| CytomX Therapeutics, Inc. (CTMX) | $714.71M | -28.5 |
| Lifecore Biomedical, Inc. (LFCR) | $172.61M | -15.2 |
| Cytokinetics, Incorporated (CYTK) | $10.69B | -9.7 |
| Assembly Biosciences, Inc. (ASMB) | $700.00M | -62.0 |
| Viridian Therapeutics, Inc. (VRDN) | $2.50B | — |
| Rockwell Medical, Inc. (RMTI) | $315.76M | — |
| Kura Oncology, Inc. (KURA) | $1.06B | -3.3 |
| Spero Therapeutics, Inc. (SPRO) | $70.93M | 9.6 |
| Aytu BioPharma, Inc. (AYTU) | $25.12M | -1.0 |
| Stock P/E | 142.9 |
| Sector P/E (Healthcare) | 21.7 |
| Industry P/E (Pharmaceutical Products) | 17.2 |
| vs Sector | 557.3% |
| vs Industry | 731.8% |
ETON overview · ETON earnings · ETON financials · ETON KPIs · ETON documents · ETON ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.